These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
8. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD; Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449 [TBL] [Abstract][Full Text] [Related]
9. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades. Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553 [TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Weber MA; Bakris GL; Dahlöf B; Pitt B; Velazquez E; Gupte J; Lefkowitz M; Hester A; Shi V; Weir M; Kjeldsen S; Massie B; Nesbitt S; Ofili E; Jamerson K Blood Press; 2007; 16(1):13-9. PubMed ID: 17453747 [TBL] [Abstract][Full Text] [Related]
11. Secondary prevention of coronary heart disease in elderly patients. Hanna IR; Wenger NK Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866 [TBL] [Abstract][Full Text] [Related]
12. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
13. Hypertension in the elderly: new and old evidence that treatment may benefit the old. Fagard RH J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990 [TBL] [Abstract][Full Text] [Related]
14. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
16. Physiologic changes in the elderly: are they clinically important in the management of hypertension? Moser M Geriatrics; 1989 Oct; 44 Suppl B():4-9. PubMed ID: 2680779 [TBL] [Abstract][Full Text] [Related]
17. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of vascular disease in hypertension with special reference to diabetes. Yudkin JS Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605 [TBL] [Abstract][Full Text] [Related]